Butorphanol Tartrate Spray, Metered
Product Images NDC 0054-3090

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Butorphanol Tartrate (NDC 0054-3090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem.jpg (Chem)

Chemical structure of Butorphanol Tartrate, showing the molecular arrangement of the active ingredient with its characteristic cycloalkane and phenol groups, along with the tartrate moiety.*

FDA Label Image

Fig1.jpg (Fig1)

An instructional illustration showing a person holding a tissue over their nose with both hands, likely demonstrating nasal care or cleaning. The person’s eyes are closed, and the focus is on the nose and hands to indicate proper handling of nasal area.*

FDA Label Image

Fig2

An instructional diagram showing a metered nasal spray bottle with arrows indicating removal of the spray nozzle cap upwards and the actuator sideways, likely to demonstrate preparation or usage steps for a nasal spray device.*

FDA Label Image

Fig3.jpg (Fig3)

An instructional illustration showing a hand holding a nasal spray bottle upright while pressing down on the actuator to release a spray mist. This depicts the use of Butorphanol Tartrate 10 mg/mL nasal spray, metered dose.*

FDA Label Image

Fig4-6.jpg (Fig4 6 01)

An instructional line drawing showing a person administering a metered nasal spray. The spray device is positioned at the nostril, with the thumb and fingers holding the bottle and the nozzle inserted into the nose.*

FDA Label Image

Fig4-6.jpg (Fig4 6)

Instructional black and white line drawing showing a person using a metered nasal spray device. The person holds the spray bottle with the nozzle inserted into one nostril, demonstrating the proper administration technique for nasal spray products.*

FDA Label Image

Fig5.jpg (Fig5)

An instructional illustration showing a person holding a nasal spray bottle near their nostril. The person is depicted with eyes closed and using one hand to insert the spray tip into one nostril while the other hand supports the bottle, preparing to administer a metered nasal spray dose.*

FDA Label Image

Fig7.jpg (Fig7)

An instructional line drawing showing the profile of a human face with a nasal spray nozzle positioned near the nostril, demonstrating the proper placement for nasal administration of a metered spray.*

FDA Label Image

Image 01

Graph depicting plasma concentration (ng/mL) over time (hours) comparing intravenous (IV), nasal spray (NS), and intramuscular (IM) administration of a drug. The curves show the concentration decline for each route up to 12 hours post-administration, with sample sizes noted for each group.*

FDA Label Image

Image-03.jpg (Image 03)

Butorphanol Tartrate Nasal Spray USP, 10 mg per mL, metered spray dosage form for nasal use only. The label includes storage instructions at 20° to 25°C (68° to 77°F) and notes that the product is for prescription use only. It is distributed by West-Ward Pharmaceuticals Corp., Eatontown, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.